Skip to main content
Clinical Trials/IRCT20190511043547N1
IRCT20190511043547N1RecruitingPhase 3

Comparison of the effectiveness of Minoxidil 5% solution, Cetirizine 1% solution and Diclofenac 3% solution in treatment of androgenic alopecia

Shahid Beheshti University of medical sciences0 sites54 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
54

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 60 years (—)
Sex
Male

Inclusion Criteria

  • 18-60 years old men with androgenetic alopecia
  • No contraindication for topical trreatment

Exclusion Criteria

  • systemic disease
  • use of other drug in treatment of androgenic alopecia
  • other pattern of hair loss

Investigators

Similar Trials